- Article metrics
- Last updated: Sun, 5 Apr 2026 21:04:05 Z
Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis
Access & Citations
-
- 13k
- Article Accesses
-
- 281
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 193 tweeters
- 7 blogs
- 3 news outlets
- 5 Wikipedia page
- 162 Mendeley
This article is in the 98th percentile (ranked 9,148th) of the 468,483 tracked articles of a similar age in all journals and the 62nd percentile (ranked 50th) of the 135 tracked articles of a similar age in Nature Medicine
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. The donut visual summarises attention from different sources; a breakdown is shown in the legend. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
《中国恶性肿瘤学科发展报告(2021)》——肾癌研究进展篇
CN-Healthcare -
Belzutifan
New Drug Approvals -
A potential new kidney cancer treatment for von Hippel-Lindau disease (VHL)
Birt-Hogg-Dubé Syndrome
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.